Multi-state operator TerrAscend has purchased a New Jersey cannabis retailer for $9 million in cash and assumed debt, expanding its presence in one of the nation's fastest-growing adult-use markets.
The acquisition gives TerrAscend five retail locations across New Jersey, strengthening its position in a state that generated over $1.9 billion in cannabis sales during its first two years of adult-use operations.
Deal Structure
The transaction includes both cash payment and debt assumption, though specific terms were not disclosed. The deal comes as multi-state operators continue consolidating retail operations in high-value markets where they already maintain cultivation and processing facilities.
TerrAscend operates vertically integrated operations in Pennsylvania, Maryland, Michigan, and California in addition to New Jersey. The company has focused recent expansion efforts on states with established medical programs that have transitioned to adult-use sales.
New Jersey launched recreational cannabis sales in April 2022, and the market has consistently exceeded projections. Monthly sales have regularly topped $150 million since mid-2023, making the state a priority target for MSO expansion.
Market Consolidation
The purchase reflects broader industry trends as larger operators acquire smaller retailers struggling with high operating costs and limited access to capital. New Jersey's regulatory framework requires significant upfront investment in compliance, security, and inventory management—expenses that have proven challenging for single-location operators.
Several New Jersey retailers have sought buyers over the past year as competition intensified. The state now has over 140 licensed dispensaries, up from just 13 medical dispensaries when adult-use sales began.
TerrAscend reported $239 million in revenue for the third quarter of 2024, with New Jersey operations contributing a growing share of total sales. The company has previously stated that New Jersey represents one of its most profitable markets due to population density and favorable tax structures compared to states like California.
What's Next
The acquisition requires approval from the New Jersey Cannabis Regulatory Commission, which typically reviews ownership changes within 60 to 90 days. TerrAscend expects to complete integration of the purchased locations by the second quarter of 2025.
Industry analysts anticipate additional consolidation in New Jersey as the market matures. Smaller operators face pressure from both large MSOs and regional chains that can leverage economies of scale for purchasing, marketing, and compliance operations.
The state's medical program, which predated adult-use legalization by several years, has seen patient counts decline as consumers shift to recreational purchases. That trend has further squeezed retailers dependent primarily on medical sales.
This article is based on original reporting by mjbizdaily.com.
